Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipilimumab + Dacarbazine in Advanced Melanoma
NCT00324155Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Aug 2006
- Primary completion
- Jan 2011
- Modality
- Monoclonal Antibodies
- Countries
- 25
01
Overview
A Phase 3 trial of ipilimumab in melanoma, sponsored by Bristol Myers Squibb. Started Aug 2006; status: completed.
02
Drugs
ipilimumab
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00324155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324155.